1 / 1

Impact Review of High-Dollar Specialty Drug Intervention in Leukemia Treatment

This case study reviews the financial implications of a specialty drug intervention using Clofarabine for leukemia treatment, with total billed costs reaching $258,550. Through strategic negotiations utilizing average wholesale pricing (AWP) tools and proprietary data, significant discounts were secured, resulting in a final payment of $42,321. The hospital provided secure sign-off, ensuring no balance billing to insured patients, and achieving a remarkable 83.6% savings of $216,229.

leona
Télécharger la présentation

Impact Review of High-Dollar Specialty Drug Intervention in Leukemia Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Impact Case Study #1 High-dollar Specialty Drug Impact Review - Revenue code 636 • Leukemia with Clofarabine InterventionTotal billed: $258,550 • An average wholesale pricing discount was negotiated based on AWP tools and proprietary data warehouse • Received secure sign off from hospital • Client received secured savings • No balance billing to insured • Amount client paid: • $42,321 $216,229(83.6%) In Savings

More Related